*Result*: A randomized phase IIa trial with temsirolimus versus sunitinib in advanced non-clear cell renal cell carcinoma: an intergroup study of the CESAR Central European Society for Anticancer Drug Research-EWIV and the Interdisciplinary Working Group on Renal Cell Cancer (IAGN) of the German Cancer Society
*Title*:
A randomized phase IIa trial with temsirolimus versus sunitinib in advanced non-clear cell renal cell carcinoma: an intergroup study of the CESAR Central European Society for Anticancer Drug Research-EWIV and the Interdisciplinary Working Group on Renal Cell Cancer (IAGN) of the German Cancer Society / Lothar Bergmann, Viktor Grünwald, Luise Maute, Marc-Oliver Grimm, Steffen Weikert, Jan Schleicher, Theodor Klotz, Jochen Greiner, Anne Flörcken, Arndt Hartmann, Thomas Gauler
*Author/editor-in-chief*:
Bergmann, Lothar (Verfasser) ; Grünwald, Viktor (Verfasser) ; Maute, Luise (Verfasser) ; Grimm, Marc-Oliver (Verfasser) ; Weikert, Steffen (Verfasser) ; Schleicher, Jan (Verfasser); Klotz, Theodor (Verfasser) ; Greiner, Jochen (Verfasser) ; Flörcken, Anne (Verfasser) ; Hartmann, Arndt (Verfasser) ; Gauler, Thomas C. (Verfasser)
*Published in*:
Oncology research and treatment. - Basel : Karger, 2014-. - Online-Ressource. - ISSN 2296-5262. - Band 43, Heft 7-8 (2021), Seite 333-338
*show_all_articles*
*show_all_articles*
*Distribution*:
Frankfurt am Main : Universitätsbibliothek Johann Christian Senckenberg
*Format*:
*Language*:
*eng*
*DOI*:
10.1159/000508450